Mpm Oncology Innovations Fund LP
10% owner at Aktis Oncology; 10% owner at Werewolf Therapeutics.
- Rank
- 541st of 809
- Companies held
- 2
- Largest holding
- AKTS, 98.0% of total
- Latest SEC filing
- Jan 12, 2026
- Listed but not counted
- $27.2M
What the $149M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Aktis Oncology AKTS Common Stock | Indirectly (see filing footnote) Reported jointly by 2 insiders; split evenly | 5,130,032 | $16.40 | $84.1M | 56.4% | Form 4, Jan 12, 2026 |
| Aktis Oncology AKTS Common Stock | Indirectly (see filing footnote) Reported jointly by 2 insiders; split evenly | 3,785,084 | $16.40 | $62.1M | 41.6% | Form 4, Jan 12, 2026 |
| Werewolf Therapeutics HOWL Common Stock | Through AM LLC Reported jointly by 2 insiders; split evenly | 2,952,360 | $0.99 | $2.9M | 2.0% | Form 4, Nov 6, 2025 |
Share counts are the amounts Mpm Oncology Innovations Fund LP reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Mpm Oncology Innovations Fund LP's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Aktis Oncology AKTS Common Stock | Through MPM Asset Management LLC Held by an investment fund or partnership | 1,655,971 | $16.40 | $27.2M | — | Form 4, Jan 12, 2026 |
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jan 12, 2026 | Bought | AKTS | 1,112,777 | $18.00 | $20.0M | View |
| Nov 6, 2025 | Sold | HOWL | 54,452 | $1.21 | $66K | View |
| Nov 5, 2025 | Sold | HOWL | 47,950 | $1.22 | $58K | View |
| Nov 4, 2025 | Sold | HOWL | 140,488 | $1.22 | $171K | View |
| Nov 3, 2025 | Sold | HOWL | 94,063 | $1.29 | $121K | View |
| Oct 31, 2025 | Sold | HOWL | 114,044 | $1.28 | $146K | View |
| Oct 30, 2025 | Sold | HOWL | 86,936 | $1.43 | $124K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 538 | Siddhi Sponsor LLC 10% owner, Siddhi Acquisition | $150M |
| 539 | Sequoia Capital Usv Xiv Holdco, Ltd. 10% owner, DoorDash | $150M |
| 540 | SCGGF III - U.S./India Management, L.P. 10% owner, DoorDash | $150M |
| 541 | Mpm Oncology Innovations Fund LP 10% owner, Aktis Oncology | $149M |
| 542 | Public Sector Pension Investment Board 10% owner, D-Wave Quantum | $149M |
| 543 | SC U.S. Growth VII Management, L.P. 10% owner, Airbnb | $149M |
| 544 | Smiths Group International Holdings Ltd Insider, ICU Medical | $147M |
Other Aktis Oncology insiders
All AKTS insiders- Todd Foley$123MDirector. #1289 overall
Questions
How much stock does Mpm Oncology Innovations Fund LP own?
Mpm Oncology Innovations Fund LP holds $149,118,929 in listed stock based on SEC filings and current prices, mostly Aktis Oncology (AKTS). That ranks 541st on the Stock Rich List.
Is this Mpm Oncology Innovations Fund LP's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Mpm Oncology Innovations Fund LP last buy or sell stock?
The most recent open-market trade on file is a purchase of 1,112,777 AKTS shares on Jan 12, 2026 at $18.00.
Files jointly with Ansbert Gadicke, SEC filer 1134657.